Britannia Life Sciences Inc. (CSE: BLAB)
Canada
· Delayed Price · Currency is CAD 0.0800
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
Britannia Life Sciences Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Mar '24 Mar 30, 2024 | Mar '23 Mar 30, 2023 | Mar '22 Mar 30, 2022 | Mar '21 Mar 30, 2021 | Mar '20 Mar 30, 2020 |
| Revenue | 7.26 | 7.57 | 6.4 | 7.3 | 1.42 | - |
| Revenue Growth (YoY) | -0.87% | 18.20% | -12.28% | 412.42% | - | - |
| Cost of Revenue | 2.85 | 2.72 | 1.77 | 2.04 | 0.25 | - |
| Gross Profit | 4.41 | 4.85 | 4.64 | 5.26 | 1.18 | - |
| Selling, General & Admin | 3.27 | 3.34 | 2.59 | 2.54 | 0.79 | 0.63 |
| Other Operating Expenses | - | - | - | - | 0.1 | - |
| Operating Expenses | 3.32 | 3.57 | 3.64 | 3.65 | 0.89 | 0.63 |
| Operating Income | 1.09 | 1.29 | 0.99 | 1.62 | 0.29 | -0.63 |
| Interest Expense | -1.21 | -1.28 | -0.85 | -2.31 | -0.36 | - |
| Earnings From Equity Investments | -1.79 | -0.96 | -0.02 | -0 | - | - |
| Currency Exchange Gain (Loss) | -1.07 | -0.11 | -0.06 | 0.61 | 0.19 | - |
| Other Non Operating Income (Expenses) | -4.73 | -3.82 | 4.41 | -3.22 | 0.29 | - |
| EBT Excluding Unusual Items | -7.72 | -4.89 | 4.47 | -3.3 | 0.41 | -0.63 |
| Impairment of Goodwill | -0.04 | -0.04 | - | - | - | - |
| Gain (Loss) on Sale of Assets | 0.54 | 0.47 | 1.39 | - | - | - |
| Other Unusual Items | - | - | - | -9.97 | -0.01 | - |
| Pretax Income | -7.21 | -4.47 | 5.86 | -13.27 | 0.4 | -0.63 |
| Income Tax Expense | -0.22 | -0.07 | 0.02 | 0.71 | 0.26 | - |
| Earnings From Continuing Operations | -6.99 | -4.4 | 5.84 | -13.99 | 0.14 | -0.63 |
| Minority Interest in Earnings | -0.31 | -0.37 | -0.75 | -1.47 | -0.3 | - |
| Net Income | -7.31 | -4.77 | 5.08 | -15.46 | -0.16 | -0.63 |
| Net Income to Common | -7.31 | -4.77 | 5.08 | -15.46 | -0.16 | -0.63 |
| Shares Outstanding (Basic) | 162 | 162 | 162 | 110 | 78 | 6 |
| Shares Outstanding (Diluted) | 162 | 162 | 162 | 110 | 78 | 6 |
| Shares Change (YoY) | 0.03% | 0.07% | 48.07% | 41.06% | 1138.07% | - |
| EPS (Basic) | -0.05 | -0.03 | 0.03 | -0.14 | -0.00 | -0.10 |
| EPS (Diluted) | -0.05 | -0.03 | 0.03 | -0.14 | -0.00 | -0.10 |
| Free Cash Flow | 0.98 | 1.96 | 1.95 | 2.71 | -0.54 | -0.5 |
| Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.02 | -0.01 | -0.08 |
| Gross Margin | 60.71% | 64.12% | 72.43% | 72.08% | 82.63% | - |
| Operating Margin | 15.07% | 17.01% | 15.52% | 22.13% | 20.23% | - |
| Profit Margin | -100.60% | -62.99% | 79.39% | -211.76% | -11.03% | - |
| Free Cash Flow Margin | 13.44% | 25.85% | 30.50% | 37.16% | -38.15% | - |
| EBITDA | 1.13 | 1.41 | 1.1 | 1.75 | 0.32 | - |
| EBITDA Margin | 15.56% | 18.64% | 17.25% | 24.02% | 22.24% | - |
| D&A For EBITDA | 0.04 | 0.12 | 0.11 | 0.14 | 0.03 | - |
| EBIT | 1.09 | 1.29 | 0.99 | 1.62 | 0.29 | -0.63 |
| EBIT Margin | 15.07% | 17.01% | 15.52% | 22.13% | 20.23% | - |
| Effective Tax Rate | - | - | 0.34% | - | 64.31% | - |
Source: S&P Capital IQ. Standard template. Financial Sources.